Structure Based Screening for Inhibitory Therapeutics of CTLA-4 Unveiled New Insights About Biology of ACTH-Reference-Cited by-同舟云学术

Structure Based Screening for Inhibitory Therapeutics of CTLA-4 Unveiled New Insights About Biology of ACTH

Published:2019-07-09 Issue:2 Volume:26 Page:849-859
ISSN:1573-3149
Container-title:International Journal of Peptide Research and Therapeutics
language:en
Short-container-title:Int J Pept Res Ther

Author:

Ramezani Aghdas,Zakeri Alireza,Mard-Soltani Maysam,Mohammadian Ali,Hashemi Zahra Sadat,Mohammadpour Hemn,Jahangiri Abolfazl,Khalili Saeed^ORCID,Rasaee Mohammad Javad

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s10989-019-09891-7.pdf

Reference65 articles.

1. Abdel-Malek Z (2001) Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58:434–441

2. Alegre M-L, Shiels H, Thompson CB, Gajewski TF (1998) Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol 161:3347–3356

3. Anderson DE, Bieganowska KD, Bar-Or A, Oliveira EM, Carreno B, Collins M, Hafler DA (2000) Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population. Nat Med 6:211–214

4. Arnason BG, Berkovich R, Catania A, Lisak RP, Zaidi M (2013) Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler J 19:130–136

5. Bazmara H, Rasooli I, Jahangiri A, Sefid F, Astaneh SDA, Payandeh Z (2019) Antigenic properties of iron regulated proteins in Acinetobacter baumannii: an in silico approach. Int J Pept Res Ther 25:205–213

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art;Cancer Cell International;2023-08-05

2. Study of Glabranin as an Inhibitor Against Prostate Cancer: Molecular Docking, Molecular Dynamics Simulation, MM-PBSA Calculation and QSAR Prediction;Indian Journal of Clinical Biochemistry;2023-04-01

3. Exosome-based strategies for diagnosis and therapy of glioma cancer;Cancer Cell International;2022-08-21

4. A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa;Scientific Reports;2022-06-27

5. Computational approaches for evaluation of isobavachin as potential inhibitor against t877a and w741l mutations in prostate cancer;Journal of Biomolecular Structure and Dynamics;2022-02-04